ALLURION TECHNOLOGIES, INC. (ALURD) has 15,006,253 shares outstanding, with 9,996,437 warrants outstanding — 66.6% of shares. The company’s cash runway is 1.9 months. Warrant overhang is the most urgent risk factor, scoring 90/100. The float is 100% public, with no short interest. The dilution overhang is 66.6% of the float.
ALLURION’s warrant overhang is 9,996,437 warrants, which represent 66.6% of the 15,006,253 shares outstanding. This level of overhang is extreme for a small-cap company. Typically, small-cap overhangs range from 10% to 30% of shares outstanding. A 66.6% overhang suggests that a significant portion of the company’s equity is effectively a future liability. If all warrants are exercised, the share count would nearly double, creating massive dilution.
The warrants are not convertible, meaning they are purely dilutive. Convertible shares, if any, would add to the overhang, but the data shows zero convertible shares outstanding. This means the only source of dilution is the warrants. Warrants often have strike prices that are above or below current stock prices. Without knowing the strike price, it's impossible to determine if the warrants are in the money. However, the sheer volume of warrants is a red flag.
That math is brutal. A 66.6% overhang means that 2/3 of the company’s equity is at risk of being issued as new shares. For a stock with a 1.9-month cash runway, this is a death spiral risk. The company needs to raise capital, and the warrants represent a future capital call that could be triggered at any time.
The 66.6% overhang of warrants and convertibles vs. the float is the highest risk factor in the DilutionWatch score. The float is 100% public, meaning all shares are available for trading. If the warrants are exercised, the float would be effectively diluted by 66.6%. This would create a huge supply of shares, potentially depressing the stock price. The company has no cash runway, so the only way to fund operations is through dilution — either through warrants, ATM, or new offerings.
What price action would trigger mass exercise? That depends on the warrant strike price, which is not disclosed. However, if the stock is trading above the strike price, the warrants would be in the money, and holders would likely exercise. If the stock is trading below the strike price, the warrants would be out of the money, and no exercise would occur. Without knowing the strike price, the exact trigger point is unknown. However, the sheer size of the overhang makes it a critical risk regardless of the strike price.
The pattern repeats. The company has filed 10 dilution events in the past 12 months. This suggests that the company is regularly seeking capital, and the warrants may be part of that strategy. If the stock price rises, the warrants could be exercised, increasing the share count and lowering the stock price. If the stock price falls, the company may have to issue more shares to raise capital, further diluting existing shareholders.
Warrant exercise can either bring in cash or result in a cashless or net share settlement. The data does not specify the terms of the warrants, so it is unclear whether exercise would bring in cash or be a pure dilution event. If the warrants are exercised for cash, the company would receive the strike price per share. If the exercise is cashless, the company would issue new shares without receiving cash, which is pure dilution.
If the warrants are exercised for cash, the company would gain $X, where X is the number of warrants times the strike price. However, with a 1.9-month cash runway, the company may not have the luxury of waiting for the warrants to be exercised. If the warrants are cashless, the dilution would be immediate and significant. Given the company’s financial position, it is more likely that the warrants would be exercised in a way that benefits the warrant holders, not the company.
Watch the cash, not the price. The company’s cash runway is a critical factor. If the warrants are exercised in a way that increases the cash balance, it could buy time. If they are exercised in a way that adds to the share count without cash, it could accelerate the dilution. The company’s ability to raise capital through warrants will determine its survival.
The warrant overhang interacts with the company’s lack of ATM capacity and a 1.9-month cash runway. The company has no ATM remaining capacity and no shelf registration capacity, meaning it cannot raise capital through a standard ATM offering. This leaves the company with limited options: either raise capital through a private placement, which is typically at a discount, or wait for the warrants to be exercised, which may or may not bring in cash.
The company has 10 dilution filings in the past 12 months, indicating a pattern of frequent capital raising. This suggests that the company is under constant pressure to raise capital, and the warrants may be part of that strategy. If the warrants are exercised, the company may not need to raise more capital immediately, but the dilution would be immediate. If the warrants are not exercised, the company may be forced to issue new shares, which would further dilute the existing shareholders.
The company’s financial position is dire. With only 1.9 months of cash runway, it cannot afford to wait for the warrants to be exercised. If the warrants are not exercised, the company may have to issue new shares, which would be a significant dilution. The warrant overhang is a double-edged sword: it could provide a cash infusion, but it could also lead to a massive increase in the share count.
The DilutionWatch score for ALLURION is 87/100, with a warrant sub-score of 90/100. This suggests that the warrant overhang is the most significant risk factor. The overall score is just 87, which is a critical risk level. The warrant sub-score is higher than the overall score because the warrant overhang is the most urgent threat. The offering ability score is 80/100, indicating that the company has the ability to raise capital, but the cash runway is so short that it may not have time to do so.
The float risk is only 25/100, which is low. This is because the float is 100% public, and there is no short interest. However, the warrant overhang is a much greater risk. The convertibles risk is 40/100, which is low, but this is because there are no convertible shares outstanding. The key to reducing the risk is to either reduce the warrant overhang or increase the cash runway. If the company can raise capital before the warrants are exercised, it could reduce the dilution risk.
The warrant overhang is the most critical risk. If the company can raise capital through a private placement or a public offering, it could reduce the need for warrant exercise. If it cannot, the dilution will be severe. The company’s financial position is so precarious that it cannot afford to wait for the warrants to be exercised. It must raise capital immediately, and the warrants are a liability, not an asset.
The most critical catalyst is the price of the stock. If the stock price rises above the strike price of the warrants, the warrants will be exercised, increasing the share count and diluting existing shareholders. If the stock price falls, the company may be forced to issue new shares, which would be a significant dilution. The exact strike price is unknown, but the company’s financial position makes it likely that the warrants will be exercised at some point.
The expiration date of the warrants is not listed, but the company’s cash runway is only 1.9 months. This means that the company may not have time to wait for the warrants to be exercised. If the warrants are not exercised, the company may have to issue new shares, which would be a significant dilution. The company has no ATM capacity, so it cannot raise capital through a standard offering. This leaves the company with limited options.
What could go wrong? If the company raises $20M at market price before the ATM is triggered, the warrant overhang would be less of a risk. If the company fails to raise capital and the warrants are exercised, the dilution would be severe. The company’s ability to raise capital is the key to its survival.
If the company raises $20M at market price before the ATM is triggered, the dilution risk would be reduced. If the company fails to raise capital, the warrants would be exercised, increasing the share count and depressing the stock price. The company has no ATM capacity, so it cannot raise capital through a standard offering.
If the company is unable to raise capital through a private placement, it may be forced to issue new shares, which would be a significant dilution. The company’s financial position is so precarious that it cannot afford to wait for the warrants to be exercised. The warrant overhang is a liability, not an asset.
My read: This is high risk. The warrant overhang is the single most urgent threat to ALURD. Watch for a S-3 drawdown within 90 days if the stock price holds above $2.50. The company has no cash runway, and the warrants are a ticking time bomb. If the stock price rises, the warrants will be exercised, and the dilution will be severe. If the stock price falls, the company may be forced to issue new shares, which would be a significant dilution. Either way, the risk is extreme. The most important trigger to watch is the stock price. If it holds above $2.50, the company may be forced to raise capital, which could trigger a new round of dilution. If it falls below that level, the dilution risk may be even worse. Either way, the risk is high. Bottom line: ALURD is a high-risk investment with a critical warrant overhang.
DilutionWatch monitors shelf registrations, ATM offerings, warrant exercises, and cash runway across thousands of public companies — updated daily from SEC filings.
Get Full Access — Free Trial →